Skip to main content
. 2019 Dec 2;92:100572. doi: 10.1016/j.curtheres.2019.100572

Table 2.

Ovarian response, oocyte, and embryo parameters from retrieval to transfer of the patients in the highly purified human menopausal gonadotropin (hp-hMG) and recombinant follicle-stimulating hormone (rFSH) groups.*

Parameter hp-hMG (n = 30) rFSH (n = 30) P value
Duration of stimulation (d) 9.20 (1.448) 9.23 (1.478) 0.93
Total Gn (IU) 2721.67 (612.961) 2570.83 (395.943) 0.263
Estradiol concentration on the day of hCG administration (pg/mL) 790.90 (319.586) 751.13 (330.30) 0.637
Endometrial thickness on the day of hCG administration (mm) 9.297 (2.0962) 9.370 (2.2530) 0.897
No. of >14 mm follicles on the day of hCG administration 3.77 (1.569) 3.50 (1.503) 0.504
No. of oocytes retrieved 2.90 (1.470) 2.70 (1.579) 0.614
No. of mature oocytes retrieved 2.53 (1.167) 2.13 (1.137) 0.184
No. of fertilized oocytes 2.30 (1.119) 1.80 (0.997) 0.073
No. of good embryos 1.83 (1.02) 1.50 (0.974) 0.201
No. of cryopreserved embryos 2.03 (1.098) 1.57 (0.935) 0.082
Oocyte retrieval rate per >14 mm follicle 87/113 (77.0) 81/105 (77.1) 0.979
Mature oocyte rate 76/87 (87.4) 63/81 (77.8) 0.101
Fertilization rate 69/76 (90.8) 54/63 (85.7) 0.351
Viable embryo rate per oocyte retrieved 61/113 (54.0) 47/105 (44.8) 0.174
Rate of moderate or serious OHSS per cycle 0 (0.0) 0 (0.0)

Gn = gonadotropin; hCG = human chorionic gonadotropin; OHSS = ovarian hyperstimulation syndrome.

Values are expressed as mean [SD] or n /N (%).

Metaphase II.